Pfizer Faces Lipitor Competition as Patent Expires

Pfizer Faces Lipitor Competition as Patent Expires Play

Nov. 1 (Bloomberg) -- Pfizer Inc., the world's largest drugmaker, is focused on bringing new drugs to market and preparing for generic competition to Lipitor, the world’s best-selling drug with $10.7 billion in annual sales. Lipitor loses patent protection this month. Shannon Pettypiece reports on Bloomberg Television's "InsideTrack." (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan Watch Now

  • Next

    Taking Stock with Pimm Fox

blog comments powered by Disqus